GlucoCheck
Pain-free Glucose Testing
Health Tech & Life Sciences
Non Active, May 2018 ceased to operate
Company Overview
Snapshot
Founded in December 2012 by Adi Kahn, GlucoCheck operates with 1–10 employees. The company ceased operations in May 2018, indicating a significant strategic shift or market challenge.
Business overview
GlucoCheck is a Health Tech & Life Sciences company focused on developing a proprietary, patent-pending solution for self-monitoring of blood glucose (SMBG). The company's core technology aims to provide pain-free, alternative-site SMBG, designed to meet FDA and medical staff requirements as a permanent replacement for traditional fingertip SMBG. GlucoCheck operates in the Medical Devices sector, specifically targeting the Medical Monitors category, and serves patients and consumers in the healthcare market.
Company Intelligence Q&A
- What is GlucoCheck's primary focus?
- GlucoCheck is developing a proprietary, patent-pending solution for pain-free, alternative-site self-monitoring of blood glucose (SMBG), intended to replace traditional fingertip SMBG.
- When was GlucoCheck founded?
- GlucoCheck was founded in December 2012.
- Who founded GlucoCheck?
- GlucoCheck was founded by Adi Kahn.
- What is the current status of GlucoCheck?
- GlucoCheck is currently non-active and ceased to operate in May 2018.
- In which sector does GlucoCheck primarily operate?
- GlucoCheck operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Monitors.